Healthcare Trust of America (HTA) 10-Q 26 Oct 16 2016 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2016	Oct. 24, 2016
Entity Information [Line Items]
Entity Registrant Name	HEALTHCARE TRUST OF AMERICA, INC.
Entity Central Index Key	1,360,604
Document Type	10-Q
Document Period End Date	Sep. 30, 2016
Amendment Flag	false
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		141,727,903
Healthcare Trust of America Holdings, LP (HTALP)
Entity Information [Line Items]
Entity Registrant Name	Healthcare Trust of America Holdings, LP
Entity Central Index Key	1,495,491
Document Type	10-Q
Document Period End Date	Sep. 30, 2016
Amendment Flag	false
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Real estate investments:
Land	$ 381,745	$ 303,706
Building and improvements	3,406,897	2,901,157
Lease intangibles	466,434	430,749
Real estate investments, gross	4,255,076	3,635,612
Accumulated depreciation and amortization	(779,378)	(676,144)
Real estate investments, net	3,475,698	2,959,468
Cash and cash equivalents	17,938	13,070
Restricted cash and escrow deposits	13,689	15,892
Receivables and other assets, net	160,837	141,703
Other intangibles, net	47,728	42,167
Total assets	3,715,890	3,172,300
Liabilities:
Debt	1,712,598	1,590,696
Accounts payable and accrued liabilities	104,202	94,933
Derivative financial instruments - interest rate swaps	4,866	2,370
Security deposits, prepaid rent and other liabilities	44,828	46,295
Intangible liabilities, net	36,928	26,611
Total liabilities	1,903,422	1,760,905
Commitments and contingencies
Redeemable noncontrolling interests	9,215	4,437
Equity/Partners' Capital:
Preferred stock, $0.01 par value; 200,000,000 shares authorized; none issued and outstanding	0	0
Class A common stock, $0.01 par value; 1,000,000,000 shares authorized; 141,728,448 and 127,026,839 shares issued and outstanding as of September 30, 2016 and December 31, 2015, respectively	1,417	1,270
Additional paid-in capital	2,753,566	2,328,806
Cumulative dividends in excess of earnings	(1,042,977)	(950,652)
Total stockholders’ equity	1,712,006	1,379,424
Noncontrolling interests	91,247	27,534
Total equity	1,803,253	1,406,958
Total liabilities and equity/partners' capital	3,715,890	3,172,300
Healthcare Trust of America Holdings, LP (HTALP)
Real estate investments:
Land	381,745	303,706
Building and improvements	3,406,897	2,901,157
Lease intangibles	466,434	430,749
Real estate investments, gross	4,255,076	3,635,612
Accumulated depreciation and amortization	(779,378)	(676,144)
Real estate investments, net	3,475,698	2,959,468
Cash and cash equivalents	17,938	13,070
Restricted cash and escrow deposits	13,689	15,892
Receivables and other assets, net	160,837	141,703
Other intangibles, net	47,728	42,167
Total assets	3,715,890	3,172,300
Liabilities:
Debt	1,712,598	1,590,696
Accounts payable and accrued liabilities	104,202	94,933
Derivative financial instruments - interest rate swaps	4,866	2,370
Security deposits, prepaid rent and other liabilities	44,828	46,295
Intangible liabilities, net	36,928	26,611
Total liabilities	1,903,422	1,760,905
Commitments and contingencies
Redeemable noncontrolling interests	9,215	4,437
Equity/Partners' Capital:
Limited partners’ capital, 4,323,095 and 1,929,942 units issued and outstanding as of September 30, 2016 and December 31, 2015, respectively	90,977	27,264
General partners’ capital, 141,728,448 and 127,026,839 units issued and outstanding as of September 30, 2016 and December 31, 2015, respectively	1,712,276	1,379,694
Total partners’ capital	1,803,253	1,406,958
Total liabilities and equity/partners' capital	$ 3,715,890	$ 3,172,300

CONDENSED CONSOLIDATED BALANCE3

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2016	Dec. 31, 2015
Equity:
Preferred stock, par value (usd per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	200,000,000	200,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Healthcare Trust of America Holdings, LP (HTALP)
Partners’ Capital:
Limited partner's capital, units issued	4,323,095	1,929,942
Limited partner's capital, units outstanding	4,323,095	1,929,942
General partner's capital, units issued	141,728,448	127,026,839
General partner's capital, units outstanding	141,728,448	127,026,839
Class A Common Stock
Equity:
Common stock, par value (usd per share)	$ 0.01	$ 0.01
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	141,728,448	127,026,839
Common stock, shares outstanding	141,728,448	127,026,839

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Revenues:
Rental income		$ 118,252	$ 103,875	$ 338,646	$ 301,570
Interest and other operating income		88	67	243	203
Total revenues		118,340	103,942	338,889	301,773
Expenses:
Rental		36,885	32,921	105,299	92,855
General and administrative		7,293	6,430	20,879	19,229
Acquisition-related		1,122	907	4,997	3,365
Depreciation and amortization		47,864	40,518	130,430	115,179
Impairment		0	0	0	1,655
Total expenses		93,164	80,776	261,605	232,283
Income before other income (expense)		25,176	23,166	77,284	69,490
Interest expense:
Interest related to derivative financial instruments		(552)	(903)	(1,856)	(2,278)
Gain (loss) on change in fair value of derivative financial instruments, net		1,306	(2,383)	(2,144)	(3,079)
Total interest related to derivative financial instruments, including net change in fair value of derivative financial instruments		754	(3,286)	(4,000)	(5,357)
Interest related to debt		(16,386)	(13,536)	(44,503)	(41,499)
Gain on sale of real estate, net		0	152	4,212	152
(Loss) gain on extinguishment of debt, net		(3,000)	(14)	(3,022)	107
Other income		95	72	220	91
Net income		6,639	6,554	30,191	22,984
Net income attributable to noncontrolling interests	[1]	(212)	(91)	(830)	(425)
Net income attributable to common stockholders/unitholders		$ 6,427	$ 6,463	$ 29,361	$ 22,559
Earnings per common share/unit - basic:
Net income attributable to common stockholders/unitholders (in usd per share)		$ 0.05	$ 0.05	$ 0.22	$ 0.18
Earnings per common share/unit - diluted:
Net income attributable to common stockholders/unitholders (in usd per share)		$ 0.04	$ 0.05	$ 0.21	$ 0.18
Weighted average common shares/units outstanding:
Basic (in shares/units)		138,807	126,863	134,905	125,750
Diluted (in shares/units)		143,138	128,793	138,314	127,680
Dividends declared per common share (in usd per share)		$ 0.300	$ 0.295	$ 0.890	$ 0.875
Healthcare Trust of America Holdings, LP (HTALP)
Revenues:
Rental income		$ 118,252	$ 103,875	$ 338,646	$ 301,570
Interest and other operating income		88	67	243	203
Total revenues		118,340	103,942	338,889	301,773
Expenses:
Rental		36,885	32,921	105,299	92,855
General and administrative		7,293	6,430	20,879	19,229
Acquisition-related		1,122	907	4,997	3,365
Depreciation and amortization		47,864	40,518	130,430	115,179
Impairment		0	0	0	1,655
Total expenses		93,164	80,776	261,605	232,283
Income before other income (expense)		25,176	23,166	77,284	69,490
Interest expense:
Interest related to derivative financial instruments		(552)	(903)	(1,856)	(2,278)
Gain (loss) on change in fair value of derivative financial instruments, net		1,306	(2,383)	(2,144)	(3,079)
Total interest related to derivative financial instruments, including net change in fair value of derivative financial instruments		754	(3,286)	(4,000)	(5,357)
Interest related to debt		(16,386)	(13,536)	(44,503)	(41,499)
Gain on sale of real estate, net		0	152	4,212	152
(Loss) gain on extinguishment of debt, net		(3,000)	(14)	(3,022)	107
Other income		95	72	220	91
Net income		6,639	6,554	30,191	22,984
Net income attributable to noncontrolling interests		(1)	(20)	(28)	(77)
Net income attributable to common stockholders/unitholders		$ 6,638	$ 6,534	$ 30,163	$ 22,907
Earnings per common share/unit - basic:
Net income attributable to common stockholders/unitholders (in usd per share)		$ 0.05	$ 0.05	$ 0.22	$ 0.18
Earnings per common share/unit - diluted:
Net income attributable to common stockholders/unitholders (in usd per share)		$ 0.05	$ 0.05	$ 0.22	$ 0.18
Weighted average common shares/units outstanding:
Basic (in shares/units)		143,137	128,793	138,314	127,781
Diluted (in shares/units)		143,137	128,793	138,314	127,781
Dividends declared per common share (in usd per share)		$ 0.300	$ 0.295	$ 0.890	$ 0.875
[1]	Includes amounts attributable to redeemable noncontrolling interests.

CONDENSED CONSOLIDATED STATEME5

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total	Class A Common Stock	Common StockClass A Common Stock	Additional Paid-In Capital	Cumulative Dividends in Excess of Earnings	Total Stockholders’ Equity	Noncontrolling Interests
Beginning balance at Dec. 31, 2014	$ 1,476,421		$ 1,251	$ 2,281,932	$ (836,044)	$ 1,447,139	$ 29,282
Beginning balance (in shares) at Dec. 31, 2014			125,087,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net	43,649		$ 18	43,631		43,649
Issuance of common stock, net (in shares)			1,800,000
Share-based award transactions, net	4,462		$ 2	4,460		4,462
Share-based award transactions, net (in shares)			200,000
Repurchase and cancellation of common stock	(1,322)		$ (1)	(1,321)		(1,322)
Repurchase and cancellation of common stock (in shares)			(49,000)
Dividends declared	(111,766)				(110,071)	(110,071)	(1,695)
Net income	22,907				22,559	22,559	348
Ending balance at Sep. 30, 2015	1,434,351		$ 1,270	2,328,702	(923,556)	1,406,416	27,935
Ending balance (in shares) at Sep. 30, 2015			127,038,000
Beginning balance at Dec. 31, 2015	1,406,958		$ 1,270	2,328,806	(950,652)	1,379,424	27,534
Beginning balance (in shares) at Dec. 31, 2015		127,026,839	127,027,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net	417,163		$ 141	417,022		417,163
Issuance of common stock, net (in shares)			14,138,000
Issuance of operating partnership units in connection with an acquisition	71,754						71,754
Share-based award transactions, net	5,136		$ 4	5,132		5,136
Share-based award transactions, net (in shares)			393,000
Repurchase and cancellation of common stock	(2,425)		$ (1)	(2,424)		(2,425)
Repurchase and cancellation of common stock (in shares)			(87,000)
Redemption of noncontrolling interest and other	(676)		$ 3	5,030		5,033	(5,709)
Redemption of noncontrolling interest and other (in shares)			257,000
Dividends declared	(124,820)				(121,686)	(121,686)	(3,134)
Net income	30,163				29,361	29,361	802
Ending balance at Sep. 30, 2016	$ 1,803,253		$ 1,417	$ 2,753,566	$ (1,042,977)	$ 1,712,006	$ 91,247
Ending balance (in shares) at Sep. 30, 2016		141,728,448	141,728,000

CONDENSED CONSOLIDATED STATEME6

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN PARTNERS' CAPITAL - USD ($) $ in Thousands	Total	Healthcare Trust of America Holdings, LP (HTALP)	Healthcare Trust of America Holdings, LP (HTALP)General Partners’ Capital	Healthcare Trust of America Holdings, LP (HTALP)Limited Partners’ Capital
Balance as of beginning of period at Dec. 31, 2014		$ 1,476,421	$ 1,447,409	$ 29,012
Balance as of beginning of period (in units) at Dec. 31, 2014			125,087,000	2,155,000
Increase (Decrease) in Partners' Capital [Roll Forward]
Issuance of general partner units, net		43,649	$ 43,649
Issuance of general partner units, net (in units)			1,800,000
Share-based award transactions, net		4,462	$ 4,462
Share-based award transactions, net (in units)			200,000	(225,000)
Redemption and cancellation of general partner units		(1,322)	$ (1,322)
Redemption and cancellation of general partner units (in units)			(49,000)
Distributions declared		(111,766)	$ (110,071)	$ (1,695)
Net income	$ 22,559	22,907	22,559	348
Balance as of end of period at Sep. 30, 2015		1,434,351	$ 1,406,686	$ 27,665
Balance as of end of period (in units) at Sep. 30, 2015			127,038,000	1,930,000
Balance as of beginning of period at Dec. 31, 2015		1,406,958	$ 1,379,694	$ 27,264
Balance as of beginning of period (in units) at Dec. 31, 2015			127,027,000	1,930,000
Increase (Decrease) in Partners' Capital [Roll Forward]
Issuance of general partner units, net		417,163	$ 417,163
Issuance of general partner units, net (in units)			14,138,000
Issuance of limited partner units in connection with an acquisition		$ 71,754		$ 71,754
Issuance of limited partner units in connection with an acquisition (in units)		2,650,409		2,650,000
Share-based award transactions, net		$ 5,136	$ 5,136
Share-based award transactions, net (in units)			393,000
Redemption and cancellation of general partner units		(2,425)	$ (2,425)
Redemption and cancellation of general partner units (in units)			(87,000)
Redemption of limited partner units and other		(676)	$ 5,033	$ (5,709)
Redemption of limited partner units and other (in units)			257,000	(257,000)
Distributions declared		(124,820)	$ (121,686)	$ (3,134)
Net income	$ 29,361	30,163	29,361	802
Balance as of end of period at Sep. 30, 2016		$ 1,803,253	$ 1,712,276	$ 90,977
Balance as of end of period (in units) at Sep. 30, 2016			141,728,000	4,323,000

CONDENSED CONSOLIDATED STATEME7

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flows from operating activities:
Net income	$ 30,191	$ 22,984
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and other	128,728	112,711
Share-based compensation expense	5,136	4,462
Bad debt expense	508	743
Gain on sale of real estate, net	(4,212)	(152)
Impairment	0	1,655
Loss (gain) on extinguishment of debt, net	3,022	(107)
Change in fair value of derivative financial instruments	2,144	3,079
Changes in operating assets and liabilities:
Receivables and other assets, net	(14,051)	(6,021)
Accounts payable and accrued liabilities	3,598	(4,124)
Prepaid rent and other liabilities	(6,807)	3,429
Net cash provided by operating activities	148,257	138,659
Cash flows from investing activities:
Investments in real estate	(532,527)	(253,107)
Proceeds from the sale of real estate	23,368	33,279
Capital expenditures	(34,064)	(17,330)
Restricted cash, escrow deposits and other assets	2,143	2,994
Net cash used in investing activities	(541,080)	(234,164)
Cash flows from financing activities:
Borrowings on unsecured revolving credit facility	513,000	387,000
Payments on unsecured revolving credit facility	(704,000)	(247,000)
Proceeds from unsecured senior notes	347,725	0
Borrowings on unsecured term loans	200,000	100,000
Payments on unsecured term loans	(155,000)	0
Payments on secured mortgage loans	(98,453)	(76,149)
Deferred financing costs	(3,039)	(289)
Security deposits	862	145
Proceeds from issuance of common stock	418,891	44,324
Repurchase and cancellation of common stock	(2,425)	(1,322)
Dividends paid	(116,655)	(108,891)
Distributions paid to noncontrolling interest of limited partners	(2,724)	(1,580)
Redemption of redeemable noncontrolling interest	(491)	0
Net cash provided by financing activities	397,691	96,238
Net change in cash and cash equivalents	4,868	733
Cash and cash equivalents - beginning of period	13,070	10,413
Cash and cash equivalents - end of period	17,938	11,146
Healthcare Trust of America Holdings, LP (HTALP)
Cash flows from operating activities:
Net income	30,191	22,984
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and other	128,728	112,711
Share-based compensation expense	5,136	4,462
Bad debt expense	508	743
Gain on sale of real estate, net	(4,212)	(152)
Impairment	0	1,655
Loss (gain) on extinguishment of debt, net	3,022	(107)
Change in fair value of derivative financial instruments	2,144	3,079
Changes in operating assets and liabilities:
Receivables and other assets, net	(14,051)	(6,021)
Accounts payable and accrued liabilities	3,598	(4,124)
Prepaid rent and other liabilities	(6,807)	3,429
Net cash provided by operating activities	148,257	138,659
Cash flows from investing activities:
Investments in real estate	(532,527)	(253,107)
Proceeds from the sale of real estate	23,368	33,279
Capital expenditures	(34,064)	(17,330)
Restricted cash, escrow deposits and other assets	2,143	2,994
Net cash used in investing activities	(541,080)	(234,164)
Cash flows from financing activities:
Borrowings on unsecured revolving credit facility	513,000	387,000
Payments on unsecured revolving credit facility	(704,000)	(247,000)
Proceeds from unsecured senior notes	347,725	0
Borrowings on unsecured term loans	200,000	100,000
Payments on unsecured term loans	(155,000)	0
Payments on secured mortgage loans	(98,453)	(76,149)
Deferred financing costs	(3,039)	(289)
Security deposits	862	145
Proceeds from issuance of general partner units	418,891	44,324
Repurchase and cancellation of general partner units	(2,425)	(1,322)
Distributions paid to general partner	(116,655)	(108,891)
Distributions paid to limited partners and redeemable noncontrolling interests	(2,724)	(1,580)
Redemption of redeemable noncontrolling interest	(491)	0
Net cash provided by financing activities	397,691	96,238
Net change in cash and cash equivalents	4,868	733
Cash and cash equivalents - beginning of period	13,070	10,413
Cash and cash equivalents - end of period	$ 17,938	$ 11,146

Organization and Description of

Organization and Description of Business	9 Months Ended
	Sep. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business HTA, a Maryland corporation, and HTALP , a Delaware limited partnership, were incorporated or formed, as applicable, on April 20, 2006 . HTA operates as a REIT and is the general partner of HTALP , which is the operating partnership. As of September 30, 2016 , HTA owned a 97.0% partnership interest and other limited partners, including some of HTA’s directors, executive officers and their affiliates, owned the remaining partnership interest (including the LTIP units) in HTALP . As the sole general partner of HTALP , HTA has the full, exclusive and complete responsibility for HTALP ’s day-to-day management and control. HTA operates in an umbrella partnership REIT structure in which HTALP and its subsidiaries hold substantially all of the assets. HTA’s only material asset is its ownership of partnership interests of HTALP . As a result, HTA does not conduct business itself, other than acting as the sole general partner of HTALP , issuing public equity from time to time and guaranteeing certain debts of HTALP . HTALP conducts the operations of the business and issues publicly-traded debt, but has no publicly-traded equity. HTA is one of the largest publicly-traded REITs focused on medical office buildings (“MOBs”) in the United States based on gross leasable area (“GLA”). HTA conducts substantially all of its operations through HTALP. We invest in MOBs that will serve the future of healthcare delivery, and these MOBs are primarily located on health system campuses, near university medical centers, or in core community outpatient locations. We also focus on our key markets that have certain demographic and macro-economic trends and where we can utilize our institutional property management and leasing platform to generate strong tenant relationships and operating cost efficiencies. Our primary objective is to maximize stockholder value with disciplined growth through strategic investments that provide an attractive risk-adjusted return for our stockholders by consistently increasing our cash flow. In pursuing this objective, we: (i) seek internal growth through proactive asset management, leasing and property management oversight; (ii) target accretive acquisitions of MOBs in markets with attractive demographics that complement our existing portfolio; and (iii) actively manage our balance sheet to maintain flexibility with conservative leverage. HTA has qualified to be taxed as a REIT for federal income tax purposes and intends to continue to be taxed as a REIT. Since 2006, we have invested $4.2 billion to create a portfolio of MOBs and other healthcare assets consisting of approximately 17.6 million square feet of GLA throughout the U.S. As of September 30, 2016 , approximately 97% of our portfolio, based on GLA, was located on the campuses of, or aligned with, nationally or regionally recognized healthcare systems. Our portfolio is diversified geographically across 31 states, with no state having more than 13% of our total GLA as of September 30, 2016 . We are concentrated in 20 to 25 key markets that are experiencing higher economic and demographic trends, than other markets, on average, that we expect will drive demand for MOBs. Approximately 92% of our portfolio, based on GLA, is located in top 75 metropolitan statistical areas (“MSAs”) including concentrations in: Albany, Atlanta, Austin, Boston, Charleston, Columbus, Dallas, Denver, Greenville, Hartford/New Haven, Honolulu, Houston, Indianapolis, Miami, Orange County/Los Angeles, Orlando, Phoenix, Pittsburgh, Raleigh, Tampa and White Plains. Our principal executive offices are located at 16435 North Scottsdale Road, Suite 320, Scottsdale, Arizona, 85254.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2016
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies The summary of significant accounting policies presented below is designed to assist in understanding our condensed consolidated financial statements. Such condensed consolidated financial statements and the accompanying notes are the representations of our management, who are responsible for their integrity and objectivity. These accounting policies conform to U.S. generally accepted accounting principles (“GAAP”) in all material respects and have been consistently applied in preparing our accompanying condensed consolidated financial statements. Basis of Presentation Our accompanying condensed consolidated financial statements include our accounts and those of our subsidiaries and any consolidated variable interest entities (“VIEs”). All inter-company balances and transactions have been eliminated in the accompanying condensed consolidated financial statements. Interim Unaudited Financial Data Our accompanying condensed consolidated financial statements have been prepared by us in accordance with GAAP in conjunction with the rules and regulations of the SEC. Certain information and footnote disclosures required for annual financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, our accompanying condensed consolidated financial statements do not include all information and footnotes required by GAAP for complete financial statements. Our accompanying condensed consolidated financial statements reflect all adjustments, which are, in our opinion, of a normal recurring nature and necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. Interim results of operations are not necessarily indicative of the results to be expected for the full year; such results may be less favorable for the full year. Our accompanying condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto included in our 2015 Annual Report on Form 10-K. There have been no significant changes to the Company’s significant accounting policies during the nine months ended September 30, 2016 , except as noted below regarding the adoption of U.S. Financial Accounting Standards Board (the “FASB”) Accounting Standards Update (“ASU”) 2015-02, Amendments to the Consolidation Analysis and ASU 2015-16, Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments. Principles of Consolidation As of January 1, 2016, the Company adopted FASB ASU 2015-02, Amendments to the Consolidation Analysis, as described below in “Recently Issued or Adopted Accounting Pronouncements”, which simplifies consolidation accounting by reducing the number of consolidation models and changing various aspects of current GAAP, including certain consolidation criteria for VIEs. The consolidated financial statements include our accounts of those of our subsidiaries and consolidated joint venture arrangements. The portions of the operating partnership not owned by us are presented as non-controlling interests in our consolidated balance sheets and statements of operations, consolidated statements of equity, and consolidated statements of changes in partners’ capital. The portions of other joint venture arrangements not owned by us are presented as redeemable non-controlling interests in our consolidated balance sheets. In addition, as described in Note 1 - Organization and Description of Business , certain third parties have been issued limited partner units in HTALP (“OP Units”). Holders of OP Units are considered to be non-controlling interest holders in HTALP and their ownership interests are reflected as equity in the consolidated balance sheets. Further, a portion of the earnings and losses of HTALP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of common shares issued and the carrying value of the OP Units converted is recorded as a component of equity. As of September 30, 2016 and December 31, 2015 , there were approximately 4.3 million and 1.9 million , respectively, of OP Units issued and outstanding. VIEs are entities where investors lack sufficient equity at risk for the entity to finance its activities without additional subordinated financial support or where equity investors, as a group, lack one of the following: (i) the power to direct the activities that most significantly impact the entity’s economic performance; (ii) the obligation to absorb the expected losses of the entity; and (iii) the right to receive the expected returns of the entity. We consolidate our investment in VIEs when we determine that we are the primary beneficiary. A primary beneficiary is one that has both: (i) the power to direct the activities of the VIE that most significantly impacts the entity’s economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. Our analysis of FASB ASU 2015-02 was concluded that our operating partnership and other joint venture arrangements are VIEs, as the limited partners in the related partnerships, although entitled to vote on certain matters, do not possess kick-out rights or substantive participating rights. Accordingly, we consolidate our interest in the operating partnership and other joint venture arrangements. Although, as we hold what is deemed a majority voting interest in the operating partnership and other joint venture arrangements, it qualifies for the exemption from providing certain of the disclosure requirements associated with investments in VIEs. We will evaluate on an ongoing basis the need to consolidate entities based on the standards set forth in GAAP as described above. Investments in Real Estate Depreciation expense of buildings and improvements for the three months ended September 30, 2016 and 2015 was $31.1 million and $26.9 million , respectively. Depreciation expense of buildings and improvements for the nine months ended September 30, 2016 and 2015 was $86.6 million and $74.9 million , respectively. Recently Issued or Adopted Accounting Pronouncements In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive new revenue recognition model requiring a company to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration (i.e., payment) to which the company expects to be entitled in exchange for those goods or services. In adopting ASU 2014-09, companies may use either a full retrospective or a modified retrospective approach. In July 2015, the FASB deferred the effective date of ASU 2014-09 to the first interim period within annual reporting periods beginning after December 15, 2017 along with the ability to early adopt as of the original effective date. We do not anticipate early adoption and we are evaluating the impact of adopting ASU 2014-09 on our consolidated financial statements. In February 2015, the FASB issued ASU 2015-02, Amendments to the Consolidation Analysis. ASU 2015-02 affects reporting entities that are required to evaluate whether they should consolidate certain legal entities. The amendments in ASU 2015-02 affect the following areas: (i) limited partnerships and similar legal entities; (ii) evaluating fees paid to a decision maker or a service provider as a variable interest; (iii) the effect of fee arrangements on the primary beneficiary determination; (iv) the effect of related parties on the primary beneficiary determination; and (v) certain investment funds. ASU 2015-02 is effective for fiscal years and for interim periods within those fiscal years, beginning after December 15, 2015 with early adoption permitted. We adopted ASU 2015-02 as of January 1, 2016. The adoption had no material impact on our interests in joint venture arrangements. Accordingly, there was no material impact on previous or current reporting periods’ consolidated financial statements. In April 2015, the FASB issued ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs. ASU 2015-03 changes the presentation of debt issuance costs by requiring these costs related to a recognized debt liability to be presented in the consolidated balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. In August 2015, the FASB issued ASU 2015-15 to include the presentation and subsequent measurement of debt issuance costs associated with line-of-credit arrangements. ASU 2015-03 and 2015-15 are effective for the fiscal years beginning after December 15, 2015, and requires retrospective application with early adoption permitted. We adopted ASU 2015-03 and 2015-15 as of December 31, 2015. As a result of the adoption, all deferred financing costs, excluding costs related to the unsecured revolving credit facility, were reclassed to debt. Unsecured revolving credit facility costs remain classified as an asset on our consolidated balance sheets and will continue to be amortized over the remaining term. The guidance requires retrospective adoption for all prior periods presented. In September 2015, the FASB issued ASU 2015-16, Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments. ASU 2015-16 eliminates the requirement that an acquirer in a business combination has to account for measurement-period adjustments retrospectively. Instead, acquirers must recognize measurement-period adjustments during the period in which they determine the amount of the adjustment, including the effect on earnings of any amounts they would have recorded in previous periods if the accounting had been completed at the acquisition date. ASU 2015-16 is effective for fiscal years beginning after December 15, 2015. We adopted ASU 2015-16 as of January 1, 2016. As a result of the adoption there was no material impact in the previous or current reporting periods’ consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, Leases. ASU 2016-02 will supersede the existing guidance for lease accounting and states that companies will be required to recognize lease assets and lease liabilities on the balance sheet and disclose key information about leasing arrangements. ASU 2016-02 requires qualitative and quantitative disclosures to supplement the amounts recorded in the financial statements so that users can understand the nature of the entity’s leasing activities, including significant judgments and changes in judgments. Within ASU 2016-02 lessor accounting remained fairly unchanged. In adopting ASU 2016-02, companies will be required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. ASU 2016-02 is effective for the fiscal years beginning after December 15, 2018 with early adoption permitted. We do not anticipate early adoption, however, we are evaluating the impact of adopting ASU 2016-02 on our consolidated financial statements. In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Compensation Accounting. ASU 2016-09 includes multiple provisions intended to simplify various aspects of accounting for share-based compensation which includes, but is not limited to, the requirement that excess tax benefits be recorded within the income statement as opposed to additional paid-in-capital and treated as an operating activity within the statement of cash flows. In addition, ASU 2016-09 allows companies to make an accounting policy election to either estimate the number of awards that are expected to vest or account for forfeitures as they occur. ASU 2016-09 is effective for fiscal years beginning after December 15, 2016 with early adoption permitted. We do not anticipate early adoption, however, we are evaluating the impact of adopting ASU 2016-09 on our consolidated financial statements. In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments (Topic 326). ASU 2016-13 is intended to improve financial reporting by requiring timelier recognition of credit losses on loans and other financial instruments that are not accounted for at fair value through net income, including loans held for investment, held-to-maturity debt securities, trade and other receivables, net investment in leases and other such commitments. ASU 2016-13 requires that financial statement assets measured at an amortized cost be presented at the net amount expected to be collected, through an allowance for credit losses that is deducted from the amortized cost basis. ASU 2016-13 is effective for the fiscal year beginning after December 15, 2019 with early adoption permitted. We do not anticipate early adoption, however, we are evaluating the impact of adopting ASU 2016-13 on our consolidated financial statements. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 includes multiple provisions intended to clarify various aspects of cash flow presentation by making eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. ASU 2016-15 is effective for fiscal years beginning after December 15, 2017 with early adoption permitted. We do not anticipate early adoption, however, we are evaluating the impact of adopting ASU 2016-15 on our consolidated financial statements.

Investments in Real Estate

Investments in Real Estate	9 Months Ended
	Sep. 30, 2016
Investments [Abstract]
Investments in Real Estate	Investments in Real Estate For the nine months ended September 30, 2016 , our investments had an aggregate purchase price of $633.0 million . We incurred $2.5 million of costs attributable to these investments, which were recorded in acquisition-related expenses in the accompanying condensed consolidated statements of operations. As part of the acquisitions, we assumed mortgage loans with an aggregate fair value of $20.0 million and issued 2,650,409 OP Units with a market value at the time of issuance of $71.8 million . The following investments were determined to be individually not significant, but significant on a collective basis. The actual revenues and earnings since the investment dates as well as the supplementary proforma information assuming these investments occurred as of the beginning of the prior periods, were not material to us. The purchase price allocation for each of our investments are preliminary and subject to change until allocations are finalized, which will be no later than 12 months from the date of acquisition. The preliminary allocations for these investments are set forth below in the aggregate for the nine months ended September 30, 2016 and 2015 (in thousands): Nine Months Ended September 30, 2016 2015 Land $ 77,949 $ 13,286 Building and improvements 505,138 229,386 In place leases 50,997 22,414 Below market leases (12,790 ) (8,206 ) Above market leases 4,413 1,254 Below market leasehold interests 4,188 2,698 Above market leasehold interests (50 ) (7,725 ) Below market debt 360 — Interest rate swaps (779 ) — Net assets acquired 629,426 253,107 Other, net 3,540 1,503 Aggregate purchase price $ 632,966 $ 254,610 The acquired intangible assets and liabilities referenced above had weighted average lives of the following for the nine months ended September 30, 2016 and 2015 (in years): Nine Months Ended September 30, 2016 2015 Acquired intangible assets 9.1 26.8 Acquired intangible liabilities 8.3 52.4 Subsequent to September 30, 2016 , we completed an investment with a purchase price of $7.2 million . The purchase price of this building was subject to certain post-closing adjustments. Due to the recent timing of the acquisition of this investment, we have not completed our initial purchase price allocation with respect to this investment and, therefore, cannot provide disclosures at this time similar to those contained in Note 3 - Investments in Real Estate to our condensed consolidated financial statements.

Dispositions

Dispositions	9 Months Ended
	Sep. 30, 2016
Disposal Group, Not Discontinued Operation, Disposal Disclosures [Abstract]
Dispositions	Dispositions During the nine months ended September 30, 2016 , we completed a disposition of four senior care facilities for an aggregate gross sales price of $26.5 million , generating a gain of $4.2 million .

Intangible Assets and Liabiliti

Intangible Assets and Liabilities	9 Months Ended
	Sep. 30, 2016
Identified Intangibles, Net [Abstract]
Intangible Assets and Liabilities	Intangible Assets and Liabilities Intangible assets and liabilities consisted of the following as of September 30, 2016 and December 31, 2015 (in thousands, except weighted average remaining amortization): September 30, 2016 December 31, 2015 Balance Weighted Average Remaining Amortization in Years Balance Weighted Average Remaining Amortization in Years Assets: In place leases $ 291,851 9.9 $ 249,824 11.0 Tenant relationships 174,583 10.5 180,925 10.4 Above market leases 28,306 6.4 24,974 6.0 Below market leasehold interests 38,795 60.4 34,606 63.0 533,535 490,329 Accumulated amortization (246,868 ) (219,334 ) Total $ 286,667 16.1 $ 270,995 16.6 Liabilities: Below market leases $ 34,125 19.1 $ 22,240 27.2 Above market leasehold interests 11,632 53.2 11,582 53.7 45,757 33,822 Accumulated amortization (8,829 ) (7,211 ) Total $ 36,928 29.0 $ 26,611 38.0 The following is a summary of the net intangible amortization for the three and nine months ended September 30, 2016 and 2015 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2016 2015 2016 2015 Amortization recorded against rental income related to above or (below) market leases $ (115 ) $ 509 $ 202 $ 1,428 Rental expense related to above or (below) market leasehold interests 118 94 321 327 Amortization expense related to in place leases and tenant relationships 15,266 12,266 39,483 36,371

Receivables and Other Assets

Receivables and Other Assets	9 Months Ended
	Sep. 30, 2016
Receivables and Other Assets [Abstract]
Receivables and Other Assets	Receivables and Other Assets Receivables and other assets consisted of the following as of September 30, 2016 and December 31, 2015 (in thousands): September 30, 2016 December 31, 2015 Tenant receivables, net $ 8,940 $ 5,820 Other receivables, net 11,311 11,882 Deferred financing costs, net 4,529 5,524 Deferred leasing costs, net 19,690 17,923 Straight-line rent receivables, net 72,354 65,543 Prepaid expenses, deposits, equipment and other, net 44,013 34,584 Derivative financial instruments - interest rate swaps — 427 Total $ 160,837 $ 141,703 The following is a summary of the amortization of deferred leasing costs and financing costs for the three and nine months ended September 30, 2016 and 2015 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2016 2015 2016 2015 Amortization expense related to deferred leasing costs $ 1,224 $ 1,013 $ 3,368 $ 2,941 Interest expense related to deferred financing costs (1) 331 320 994 985 (1) For the three and nine months ended September 30, 2015, amounts have been adjusted to reflect the retrospective presentation of the early adoption of ASU 2015-03 and 2015-15 as of December 31, 2015.

Debt

Debt	9 Months Ended
	Sep. 30, 2016
Debt Disclosure [Abstract]
Debt	Debt Debt consisted of the following as of September 30, 2016 and December 31, 2015 (in thousands): September 30, 2016 December 31, 2015 Unsecured revolving credit facility $ 27,000 $ 218,000 Unsecured term loans 500,000 455,000 Unsecured senior notes 950,000 600,000 Fixed rate mortgages loans 209,797 298,030 Variable rate mortgages loans 39,140 28,988 1,725,937 1,600,018 Deferred financing costs, net (9,853 ) (8,411 ) Discount, net (3,486 ) (911 ) Total $ 1,712,598 $ 1,590,696 Unsecured Credit Agreement Unsecured Revolving Credit Facility On February 11, 2015 , we executed an amendment to the unsecured revolving credit and term loan facility (the “Unsecured Credit Agreement”) which increased the amount available under the unsecured revolving credit facility to $850.0 million . The actual amount of credit available to us is a function of certain loan-to-value and debt service coverage ratios set forth in the unsecured revolving credit facility. The maximum principal amount of the unsecured revolving credit facility may be increased, subject to additional financing being provided by our existing lenders or new lenders being added to the unsecured revolving credit facility. The unsecured revolving credit facility matures on January 31, 2020 and is guaranteed by HTA. Borrowings under the unsecured revolving credit facility accrue interest at a rate equal to adjusted LIBOR , plus a margin ranging from 0.88% to 1.55% per annum based on our credit rating. We also pay a facility fee ranging from 0.13% to 0.30% per annum on the aggregate commitments under the unsecured revolving credit facility. As of September 30, 2016 , the margin associated with our borrowings was 1.05% per annum and the facility fee was 0.20% per annum. Unsecured Term Loan As of September 30, 2016 , we had a $300.0 million unsecured term loan outstanding that was guaranteed by HTA. Borrowings accrue interest at a rate equal to adjusted LIBOR , plus a margin ranging from 0.90% to 1.80% per annum based on our credit rating. The margin associated with our borrowings as of September 30, 2016 was 1.15% per annum. Including the impact of the interest rate swaps associated with our unsecured term loan, the interest rate was 1.65% per annum, based on our current credit rating. The unsecured term loan matures on January 31, 2019 , and includes a one -year extension exercisable at the option of the borrower, subject to certain conditions. $200.0 Million Unsecured Term Loan On September 26, 2016 , HTALP executed a $200.0 million unsecured term loan due on September 26, 2023 . Proceeds were used to refinance our $155.0 million unsecured term loan due on July 19, 2019 and pay down existing mortgage loans. Borrowings under the unsecured term loan accrue interest at a rate equal to LIBOR, plus a margin ranging from 1.50% to 2.45% per annum based on our credit rating. The margin associated with our borrowings as of September 30, 2016 was 1.65% per annum. HTALP had interest rate swaps in place that fix the interest rate at 2.76% per annum, based on our current credit rating. As of September 30, 2016 , HTALP had a $200.0 million unsecured term loan outstanding. $300.0 Million Unsecured Senior Notes due 2021 As of September 30, 2016 , HTALP had $300.0 million of unsecured senior notes outstanding that are guaranteed by HTA and that mature on July 15, 2021 . The unsecured senior notes are registered under the Securities Act of 1933, as amended (the “Securities Act”), bear interest at 3.38% per annum and are payable semi-annually. The unsecured senior notes were offered at 99.21% of the principal amount thereof, with an effective yield to maturity of 3.50% per annum. $300.0 Million Unsecured Senior Notes due 2023 As of September 30, 2016 , HTALP had $300.0 million of unsecured senior notes outstanding that are guaranteed by HTA and that mature on April 15, 2023 . The unsecured senior notes are registered under the Securities Act, bear interest at 3.70% per annum and are payable semi-annually. The unsecured senior notes were offered at 99.19% of the principal amount thereof, with an effective yield to maturity of 3.80% per annum. $350.0 million Unsecured Senior Notes due 2026 On July 12, 2016 , HTALP executed $350.0 million unsecured senior notes that are guaranteed by HTA. The unsecured senior notes are registered under the Securities Act, bear interest at 3.50% per annum and are payable semi-annually. The unsecured senior notes were offered at 99.72% of the principal amount thereof, with an effective yield to maturity of 3.53% per annum. As of September 30, 2016 , HTALP had $350.0 million of unsecured senior notes outstanding that mature on August 1, 2026 . Fixed and Variable Rate Mortgages Loans As of September 30, 2016 , HTALP and its subsidiaries had fixed and variable rate mortgages loans with interest rates ranging from 1.95% to 6.26% per annum and a weighted average interest rate of 5.03% per annum. Including the impact of the interest rate swap associated with our variable rate mortgage loans, the weighted average interest rate was 5.43% per annum. Future Debt Maturities The following table summarizes the debt maturities and scheduled principal repayments of our indebtedness as of September 30, 2016 (in thousands): Year Amount 2016 $ 1,433 2017 87,268 2018 4,333 2019 304,580 2020 76,796 Thereafter 1,251,527 Total $ 1,725,937 The above scheduled debt maturities do not include the extension available to us under the Unsecured Credit Agreement as discussed above. Deferred Financing Costs As of September 30, 2016 , the future amortization of deferred financing costs is as follows (in thousands): Year Amount 2016 $ 481 2017 1,829 2018 1,757 2019 1,762 2020 1,320 Thereafter 2,704 Total $ 9,853 We are required by the terms of our applicable debt agreements to meet various affirmative and negative covenants that we believe are customary for these types of facilities, such as limitations on the incurrence of debt by us and our subsidiaries that own unencumbered assets, limitations on the nature of HTALP ’s business, and limitations on distributions by HTALP and its subsidiaries that own unencumbered assets. Our debt agreements also impose various financial covenants on us, such as a maximum ratio of total indebtedness to total asset value, a minimum ratio of EBITDA to fixed charges, a minimum tangible net worth covenant, a maximum ratio of unsecured indebtedness to unencumbered asset value, rent coverage ratios and a minimum ratio of unencumbered net operating income to unsecured interest expense. As of September 30, 2016 , we believe that we were in compliance with all such financial covenants and reporting requirements. In addition, certain of our debt agreements include events of default provisions that we believe are customary for these types of facilities, including restricting HTA from making dividend distributions to its stockholders in the event HTA is in default thereunder, except to the extent necessary for HTA to maintain its REIT status.

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
	Sep. 30, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The following table lists the derivative financial instrument assets and (liabilities) held by us as of September 30, 2016 (in thousands): Notional Amount Index Rate Fair Value Instrument Maturity $ 50,000 LIBOR 1.39 % $ (729 ) Swap 7/17/2019 105,000 LIBOR 1.24 (1,073 ) Swap 7/17/2019 25,480 LIBOR + 1.45% 4.98 (2,224 ) Swap 5/1/2020 6,135 LIBOR + 2.25% 4.04 (243 ) Swap 1/1/2023 4,406 LIBOR + 0.49% 3.52 (597 ) Swap 12/1/2023 The following table lists the derivative financial instrument assets and (liabilities) held by us as of December 31, 2015 (in thousands): Notional Amount Index Rate Fair Value Instrument Maturity $ 100,000 LIBOR 0.86 % $ (142 ) Swap 6/15/2016 50,000 LIBOR 1.39 (71 ) Swap 7/17/2019 105,000 LIBOR 1.24 427 Swap 7/17/2019 26,092 LIBOR + 1.45% 4.98 (2,157 ) Swap 5/1/2020 As of September 30, 2016 and December 31, 2015 , the gross fair value of our derivative financial instruments was as follows (in thousands): Asset Derivatives Liability Derivatives Fair Value Fair Value Derivatives Not Designated as Hedging Instruments: Balance Sheet Location September 30, 2016 December 31, 2015 Balance Sheet Location September 30, 2016 December 31, 2015 Interest rate swaps Receivables and other assets $ — $ 427 Derivative financial instruments $ 4,866 $ 2,370 There were no derivatives offset in our accompanying condensed consolidated balance sheets as of September 30, 2016 and December 31, 2015 . As of September 30, 2016 and December 31, 2015 , we had derivatives subject to enforceable master netting arrangements which allowed for net cash settlement with the respective counterparties (in thousands): September 30, 2016 December 31, 2015 Gross Amounts Amounts Subject to Enforceable Master Netting Arrangements Net Amounts Gross Amounts Amounts Subject to Enforceable Master Netting Arrangements Net Amounts Asset derivatives $ — $ — $ — $ 427 $ (427 ) $ — Liability derivatives 4,866 — 4,866 2,370 (427 ) 1,943 We have agreements with each of our interest rate swap derivative counterparties which provide that if we default on certain of our unsecured indebtedness, our counterparties could declare us in default on our interest rate swap derivative obligations resulting in an acceleration of the indebtedness. In addition, we are exposed to credit risk in the event of non-performance by our derivative counterparties. We believe we mitigate the credit risk by entering into agreements with credit-worthy counterparties. We record counterparty credit risk valuation adjustments on interest rate swap derivative assets in order to properly reflect the credit quality of the counterparty. In addition, our fair value of interest rate swap derivative liabilities is adjusted to reflect the impact of our credit quality. As of September 30, 2016 , there have been no termination events or events of default related to our interest rate swaps.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation We are not presently subject to any material litigation nor, to our knowledge, is any material litigation threatened against us, which if determined unfavorably to us, would have a material effect on our condensed consolidated financial position, results of operations or cash flows. Environmental Matters We follow the policy of monitoring our properties for the presence of hazardous or toxic substances. While there can be no assurance that a material environmental liability does not exist at our properties, we are not currently aware of any environmental liability with respect to our properties that would have a material effect on our condensed consolidated financial position, results of operations or cash flows. Further, we are not aware of any material environmental liability or any unasserted claim or assessment with respect to an environmental liability at our properties that we believe would require additional disclosure or the recording of a loss contingency. Other Our other commitments and contingencies include the usual obligations of real estate owners and operators in the normal course of business. In our opinion, these matters are not expected to have a material effect on our condensed consolidated financial position, results of operations or cash flows.

Stockholders' Equity and Partne

Stockholders' Equity and Partners' Capital	9 Months Ended
	Sep. 30, 2016
Equity [Abstract]
Stockholders' Equity and Partners' Capital	Stockholders’ Equity and Partners’ Capital HTALP ’s partnership agreement provides that it will distribute cash flow from operations and net sale proceeds to its partners in accordance with their overall ownership interests at such times and in such amounts as the general partner determines. Dividend distributions are made such that a holder of one partnership unit in HTALP will receive distributions from HTALP in an amount equal to the dividend distributions paid to the holder of one share of HTA’s common stock. In addition, for each share of common stock issued or redeemed by HTA, HTALP issues or redeems a corresponding number of partnership units. During the nine months ended September 30, 2016 , HTA issued $492.5 million of equity at an average price of $29.33 per share. Common Stock Offerings In January 2016, HTA entered into a new equity distribution agreement with respect to its at-the-market (“ATM”) offering program of common stock with an aggregate sales amount of up to $300.0 million . During the nine months ended September 30, 2016 , HTA issued and sold 4,418,571 shares of its common stock for $122.9 million at an average price of $27.82 per share, and as of September 30, 2016 , $177.1 million remained available for issuance under the ATM. During the nine months ended September 30, 2016 , HTA completed underwritten public offerings with a cumulative 9,720,000 shares of common stock for $297.8 million at an average price of $30.64 per share. Common Unit Offerings During the nine months ended September 30, 2016 , HTA issued 2,650,409 OP Units in HTALP , respectively, for approximately $71.8 million in connection with acquisition transactions. Common Stock Dividends See our accompanying condensed consolidated statements of operations for the dividends declared during the three and nine months ended September 30, 2016 and 2015 . On October 25, 2016 , HTA declared a quarterly cash dividend of $0.30 per share to be paid on January 10, 2017 to stockholders of record of its common stock on January 3, 2017 . Incentive Plan HTA’s Amended and Restated 2006 Incentive Plan (the “Plan”) permits the grant of incentive awards to our employees, officers, non-employee directors and consultants as selected by our Board of Directors. The Plan authorizes the granting of awards in any of the following forms: options; stock appreciation rights; restricted stock; restricted or deferred stock units; performance awards; dividend equivalents; other stock-based awards, including units in HTALP ; and cash-based awards. Subject to adjustment as provided in the Plan, the aggregate number of awards reserved and available for issuance under the Plan is 5,000,000 . As of September 30, 2016 , there were 1,921,610 awards available for grant under the Plan. LTIP Units Awards under the LTIP consist of Series C units in HTALP and were subject to the achievement of certain performance and market conditions in order to vest. O nce vested, the Series C units were converted into common units of HTALP , which may be converted into shares of HTA’s common stock. The LTIP awards were fully expensed in 2013, except for 225,000 units that were forfeited in 2015 . Restricted Common Stock For the three and nine months ended September 30, 2016 , we recognized compensation expense of $2.1 million and $5.1 million , respectively. For the three and nine months ended September 30, 2015 , we recognized compensation expense of $1.4 million and $4.5 million , respectively. Compensation expense for the three and nine months ended September 30, 2016 and 2015 were recorded in general and administrative expenses in the accompanying condensed consolidated statements of operations. As of September 30, 2016 , there was $10.2 million of unrecognized compensation expense net of estimated forfeitures, which will be recognized over a remaining weighted average period of 2.0 years. The following is a summary of our restricted common stock activity during the nine months ended September 30, 2016 and 2015 (in thousands, except weighted average grant date fair value): September 30, 2016 September 30, 2015 Restricted Common Stock Weighted Average Grant Date Fair Value Restricted Common Stock Weighted Average Grant Date Fair Value Beginning balance 487,850 $ 23.13 463,050 $ 20.90 Granted 417,110 29.82 221,076 26.57 Vested (236,749 ) 23.27 (135,213 ) 21.89 Forfeited (24,391 ) 25.93 (21,378 ) 22.70 Ending balance 643,820 $ 27.35 527,535 $ 22.88

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2016
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments Financial Instruments Reported at Fair Value - Recurring The table below presents our assets and liabilities measured at fair value on a recurring basis as of September 30, 2016 , aggregated by the applicable level in the fair value hierarchy (in thousands): Level 1 Level 2 Level 3 Total Assets: Derivative financial instruments $ — $ — $ — $ — Liabilities: Derivative financial instruments $ — $ 4,866 $ — $ 4,866 The table below presents our assets and liabilities measured at fair value on a recurring basis as of December 31, 2015 , aggregated by the applicable level in the fair value hierarchy (in thousands): Level 1 Level 2 Level 3 Total Assets: Derivative financial instruments $ — $ 427 $ — $ 427 Liabilities: Derivative financial instruments $ — $ 2,370 $ — $ 2,370 Financial Instruments Reported at Fair Value - Non-Recurring As of September 30, 2016 , there were no a ssets measured at fair value on a non-recurring basis. The table below presents our assets measured at fair value on a non-recurring basis as of December 31, 2015 , aggregated by the applicable level in the fair value hierarchy (in thousands): Level 1 Level 2 Level 3 Total Assets: MOB (1) $ — $ 547 $ — $ 547 (1) During the year ended December 31, 2015, we recognized a $0.9 million impairment charge to the carrying value of an MOB. The estimated fair value as of December 31, 2015 was based upon a pending sales agreement pertaining to this MOB. There have been no transfers of assets or liabilities between levels. We will record any such transfers at the end of the reporting period in which a change of event occurs that results in a transfer. Although we have determined that the majority of the inputs used to value our interest rate swap derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with these instruments utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. However, we have assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our interest rate swap derivative positions and have determined that the credit valuation adjustments are not significant to their overall valuation. As a result, we have determined that our interest rate swap derivative valuations in their entirety are classified in Level 2 of the fair value hierarchy. Financial Instruments Disclosed at Fair Value We consider the carrying values of cash and cash equivalents, tenant and other receivables, restricted cash and escrow deposits and accounts payable, and accrued liabilities, to approximate fair value for these financial instruments because of the short period of time between origination of the instruments and their expected realization. All of these financial instruments are considered Level 2. The fair value of debt is estimated using borrowing rates available to us with similar terms and maturities, which is considered a Level 2 input. As of September 30, 2016 , the fair value of the debt was $1,781.6 million compared to the carrying value of $1,712.6 million . As of December 31, 2015 , the fair value of the debt was $1,619.7 million compared to the carrying value of $1,590.7 million .

Per Share Data of HTA

Per Share Data of HTA	9 Months Ended
	Sep. 30, 2016
HTA, Inc.
Earnings Per Share
Per Share Data of HTA	Per Share Data of HTA HTA includes unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents as “participating securities” pursuant to the two-class method. The resulting classes are our common stock and restricted stock. For the three and nine months ended September 30, 2016 and 2015 , all of HTA’s earnings were distributed and the calculated earnings per share amount would be the same for all classes. The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per share of HTA for the three and nine months ended September 30, 2016 and 2015 (in thousands, except per share data): Three Months Ended September 30, Nine Months Ended September 30, 2016 2015 2016 2015 Numerator: Net income $ 6,639 $ 6,554 $ 30,191 $ 22,984 Net income attributable to noncontrolling interests (212 ) (91 ) (830 ) (425 ) Net income attributable to common stockholders $ 6,427 $ 6,463 $ 29,361 $ 22,559 Denominator: Weighted average shares outstanding - basic 138,807 126,863 134,905 125,750 Dilutive shares 4,331 1,930 3,409 1,930 Weighted average shares outstanding - diluted 143,138 128,793 138,314 127,680 Earnings per common share - basic Net income attributable to common stockholders $ 0.05 $ 0.05 $ 0.22 $ 0.18 Earnings per common share - diluted Net income attributable to common stockholders $ 0.04 $ 0.05 $ 0.21 $ 0.18

Per Unit Data of HTALP

Per Unit Data of HTALP	9 Months Ended
	Sep. 30, 2016
Healthcare Trust of America Holdings, LP (HTALP)
Earnings Per Share
Per Unit Data of HTALP	Per Unit Data of HTALP The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per unit of HTALP for the three and nine months ended September 30, 2016 and 2015 (in thousands, except per unit data): Three Months Ended September 30, Nine Months Ended September 30, 2016 2015 2016 2015 Numerator: Net income $ 6,639 $ 6,554 $ 30,191 $ 22,984 Net income attributable to noncontrolling interests (1 ) (20 ) (28 ) (77 ) Net income attributable to common unitholders $ 6,638 $ 6,534 $ 30,163 $ 22,907 Denominator: Weighted average units outstanding - basic 143,137 128,793 138,314 127,781 Dilutive units — — — — Weighted average units outstanding - diluted 143,137 128,793 138,314 127,781 Earnings per common unit - basic: Net income attributable to common unitholders $ 0.05 $ 0.05 $ 0.22 $ 0.18 Earnings per common unit - diluted: Net income attributable to common unitholders $ 0.05 $ 0.05 $ 0.22 $ 0.18

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	9 Months Ended
	Sep. 30, 2016
Supplemental Cash Flow Elements [Abstract]
Supplemental Cash Flow Information	Supplemental Cash Flow Information The following is the supplemental cash flow information for the nine months ended September 30, 2016 and 2015 (in thousands): Nine Months Ended September 30, 2016 2015 Supplemental Disclosure of Cash Flow Information: Interest paid $ 39,321 $ 39,570 Income taxes paid 934 790 Supplemental Disclosure of Noncash Investing and Financing Activities: Accrued capital expenditures $ 2,868 $ 1,833 Debt and interest rate swaps assumed in connection with an acquisition 21,156 — Dividend distributions declared, but not paid 43,530 37,712 Issuance of operating partnership units in connection with an acquisition 71,754 — Note receivable included in the consideration of a disposition 3,000 — Redeemable noncontrolling interest assumed in connection with an acquisition 5,449 — Redemption of noncontrolling interests 5,709 —

Summary of Significant Accoun22

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2016
Accounting Policies [Abstract]
Basis of Presentation	Our accompanying condensed consolidated financial statements include our accounts and those of our subsidiaries and any consolidated variable interest entities (“VIEs”). All inter-company balances and transactions have been eliminated in the accompanying condensed consolidated financial statements.
Interim Unaudited Financial Data	Our accompanying condensed consolidated financial statements have been prepared by us in accordance with GAAP in conjunction with the rules and regulations of the SEC. Certain information and footnote disclosures required for annual financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, our accompanying condensed consolidated financial statements do not include all information and footnotes required by GAAP for complete financial statements. Our accompanying condensed consolidated financial statements reflect all adjustments, which are, in our opinion, of a normal recurring nature and necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. Interim results of operations are not necessarily indicative of the results to be expected for the full year; such results may be less favorable for the full year. Our accompanying condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto included in our 2015 Annual Report on Form 10-K. There have been no significant changes to the Company’s significant accounting policies during the nine months ended September 30, 2016 , except as noted below regarding the adoption of U.S. Financial Accounting Standards Board (the “FASB”) Accounting Standards Update (“ASU”) 2015-02, Amendments to the Consolidation Analysis and ASU 2015-16, Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments.
Principles of Consolidation	As of January 1, 2016, the Company adopted FASB ASU 2015-02, Amendments to the Consolidation Analysis, as described below in “Recently Issued or Adopted Accounting Pronouncements”, which simplifies consolidation accounting by reducing the number of consolidation models and changing various aspects of current GAAP, including certain consolidation criteria for VIEs. The consolidated financial statements include our accounts of those of our subsidiaries and consolidated joint venture arrangements. The portions of the operating partnership not owned by us are presented as non-controlling interests in our consolidated balance sheets and statements of operations, consolidated statements of equity, and consolidated statements of changes in partners’ capital. The portions of other joint venture arrangements not owned by us are presented as redeemable non-controlling interests in our consolidated balance sheets. In addition, as described in Note 1 - Organization and Description of Business , certain third parties have been issued limited partner units in HTALP (“OP Units”). Holders of OP Units are considered to be non-controlling interest holders in HTALP and their ownership interests are reflected as equity in the consolidated balance sheets. Further, a portion of the earnings and losses of HTALP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of common shares issued and the carrying value of the OP Units converted is recorded as a component of equity. As of September 30, 2016 and December 31, 2015 , there were approximately 4.3 million and 1.9 million , respectively, of OP Units issued and outstanding. VIEs are entities where investors lack sufficient equity at risk for the entity to finance its activities without additional subordinated financial support or where equity investors, as a group, lack one of the following: (i) the power to direct the activities that most significantly impact the entity’s economic performance; (ii) the obligation to absorb the expected losses of the entity; and (iii) the right to receive the expected returns of the entity. We consolidate our investment in VIEs when we determine that we are the primary beneficiary. A primary beneficiary is one that has both: (i) the power to direct the activities of the VIE that most significantly impacts the entity’s economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. Our analysis of FASB ASU 2015-02 was concluded that our operating partnership and other joint venture arrangements are VIEs, as the limited partners in the related partnerships, although entitled to vote on certain matters, do not possess kick-out rights or substantive participating rights. Accordingly, we consolidate our interest in the operating partnership and other joint venture arrangements. Although, as we hold what is deemed a majority voting interest in the operating partnership and other joint venture arrangements, it qualifies for the exemption from providing certain of the disclosure requirements associated with investments in VIEs. We will evaluate on an ongoing basis the need to consolidate entities based on the standards set forth in GAAP as described above.
Recently Issued or Adopted Accounting Pronouncements	In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive new revenue recognition model requiring a company to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration (i.e., payment) to which the company expects to be entitled in exchange for those goods or services. In adopting ASU 2014-09, companies may use either a full retrospective or a modified retrospective approach. In July 2015, the FASB deferred the effective date of ASU 2014-09 to the first interim period within annual reporting periods beginning after December 15, 2017 along with the ability to early adopt as of the original effective date. We do not anticipate early adoption and we are evaluating the impact of adopting ASU 2014-09 on our consolidated financial statements. In February 2015, the FASB issued ASU 2015-02, Amendments to the Consolidation Analysis. ASU 2015-02 affects reporting entities that are required to evaluate whether they should consolidate certain legal entities. The amendments in ASU 2015-02 affect the following areas: (i) limited partnerships and similar legal entities; (ii) evaluating fees paid to a decision maker or a service provider as a variable interest; (iii) the effect of fee arrangements on the primary beneficiary determination; (iv) the effect of related parties on the primary beneficiary determination; and (v) certain investment funds. ASU 2015-02 is effective for fiscal years and for interim periods within those fiscal years, beginning after December 15, 2015 with early adoption permitted. We adopted ASU 2015-02 as of January 1, 2016. The adoption had no material impact on our interests in joint venture arrangements. Accordingly, there was no material impact on previous or current reporting periods’ consolidated financial statements. In April 2015, the FASB issued ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs. ASU 2015-03 changes the presentation of debt issuance costs by requiring these costs related to a recognized debt liability to be presented in the consolidated balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. In August 2015, the FASB issued ASU 2015-15 to include the presentation and subsequent measurement of debt issuance costs associated with line-of-credit arrangements. ASU 2015-03 and 2015-15 are effective for the fiscal years beginning after December 15, 2015, and requires retrospective application with early adoption permitted. We adopted ASU 2015-03 and 2015-15 as of December 31, 2015. As a result of the adoption, all deferred financing costs, excluding costs related to the unsecured revolving credit facility, were reclassed to debt. Unsecured revolving credit facility costs remain classified as an asset on our consolidated balance sheets and will continue to be amortized over the remaining term. The guidance requires retrospective adoption for all prior periods presented. In September 2015, the FASB issued ASU 2015-16, Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments. ASU 2015-16 eliminates the requirement that an acquirer in a business combination has to account for measurement-period adjustments retrospectively. Instead, acquirers must recognize measurement-period adjustments during the period in which they determine the amount of the adjustment, including the effect on earnings of any amounts they would have recorded in previous periods if the accounting had been completed at the acquisition date. ASU 2015-16 is effective for fiscal years beginning after December 15, 2015. We adopted ASU 2015-16 as of January 1, 2016. As a result of the adoption there was no material impact in the previous or current reporting periods’ consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, Leases. ASU 2016-02 will supersede the existing guidance for lease accounting and states that companies will be required to recognize lease assets and lease liabilities on the balance sheet and disclose key information about leasing arrangements. ASU 2016-02 requires qualitative and quantitative disclosures to supplement the amounts recorded in the financial statements so that users can understand the nature of the entity’s leasing activities, including significant judgments and changes in judgments. Within ASU 2016-02 lessor accounting remained fairly unchanged. In adopting ASU 2016-02, companies will be required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. ASU 2016-02 is effective for the fiscal years beginning after December 15, 2018 with early adoption permitted. We do not anticipate early adoption, however, we are evaluating the impact of adopting ASU 2016-02 on our consolidated financial statements. In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Compensation Accounting. ASU 2016-09 includes multiple provisions intended to simplify various aspects of accounting for share-based compensation which includes, but is not limited to, the requirement that excess tax benefits be recorded within the income statement as opposed to additional paid-in-capital and treated as an operating activity within the statement of cash flows. In addition, ASU 2016-09 allows companies to make an accounting policy election to either estimate the number of awards that are expected to vest or account for forfeitures as they occur. ASU 2016-09 is effective for fiscal years beginning after December 15, 2016 with early adoption permitted. We do not anticipate early adoption, however, we are evaluating the impact of adopting ASU 2016-09 on our consolidated financial statements. In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments (Topic 326). ASU 2016-13 is intended to improve financial reporting by requiring timelier recognition of credit losses on loans and other financial instruments that are not accounted for at fair value through net income, including loans held for investment, held-to-maturity debt securities, trade and other receivables, net investment in leases and other such commitments. ASU 2016-13 requires that financial statement assets measured at an amortized cost be presented at the net amount expected to be collected, through an allowance for credit losses that is deducted from the amortized cost basis. ASU 2016-13 is effective for the fiscal year beginning after December 15, 2019 with early adoption permitted. We do not anticipate early adoption, however, we are evaluating the impact of adopting ASU 2016-13 on our consolidated financial statements. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 includes multiple provisions intended to clarify various aspects of cash flow presentation by making eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. ASU 2016-15 is effective for fiscal years beginning after December 15, 2017 with early adoption permitted. We do not anticipate early adoption, however, we are evaluating the impact of adopting ASU 2016-15 on our consolidated financial statements.

Investments in Real Estate (Tab

Investments in Real Estate (Tables)	9 Months Ended
	Sep. 30, 2016
Investments [Abstract]
Schedule of Purchase Price Allocation	The following investments were determined to be individually not significant, but significant on a collective basis. The actual revenues and earnings since the investment dates as well as the supplementary proforma information assuming these investments occurred as of the beginning of the prior periods, were not material to us. The purchase price allocation for each of our investments are preliminary and subject to change until allocations are finalized, which will be no later than 12 months from the date of acquisition. The preliminary allocations for these investments are set forth below in the aggregate for the nine months ended September 30, 2016 and 2015 (in thousands): Nine Months Ended September 30, 2016 2015 Land $ 77,949 $ 13,286 Building and improvements 505,138 229,386 In place leases 50,997 22,414 Below market leases (12,790 ) (8,206 ) Above market leases 4,413 1,254 Below market leasehold interests 4,188 2,698 Above market leasehold interests (50 ) (7,725 ) Below market debt 360 — Interest rate swaps (779 ) — Net assets acquired 629,426 253,107 Other, net 3,540 1,503 Aggregate purchase price $ 632,966 $ 254,610
Schedule of Weighted Average Lives of Acquired Intangible Assets and Liabilities	The acquired intangible assets and liabilities referenced above had weighted average lives of the following for the nine months ended September 30, 2016 and 2015 (in years): Nine Months Ended September 30, 2016 2015 Acquired intangible assets 9.1 26.8 Acquired intangible liabilities 8.3 52.4

Intangible Assets and Liabili24

Intangible Assets and Liabilities (Tables)	9 Months Ended
	Sep. 30, 2016
Identified Intangibles, Net [Abstract]
Schedule of Intangible Assets and Liabilities	Intangible assets and liabilities consisted of the following as of September 30, 2016 and December 31, 2015 (in thousands, except weighted average remaining amortization): September 30, 2016 December 31, 2015 Balance Weighted Average Remaining Amortization in Years Balance Weighted Average Remaining Amortization in Years Assets: In place leases $ 291,851 9.9 $ 249,824 11.0 Tenant relationships 174,583 10.5 180,925 10.4 Above market leases 28,306 6.4 24,974 6.0 Below market leasehold interests 38,795 60.4 34,606 63.0 533,535 490,329 Accumulated amortization (246,868 ) (219,334 ) Total $ 286,667 16.1 $ 270,995 16.6 Liabilities: Below market leases $ 34,125 19.1 $ 22,240 27.2 Above market leasehold interests 11,632 53.2 11,582 53.7 45,757 33,822 Accumulated amortization (8,829 ) (7,211 ) Total $ 36,928 29.0 $ 26,611 38.0
Summary of Net Intangible Amortization	The following is a summary of the net intangible amortization for the three and nine months ended September 30, 2016 and 2015 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2016 2015 2016 2015 Amortization recorded against rental income related to above or (below) market leases $ (115 ) $ 509 $ 202 $ 1,428 Rental expense related to above or (below) market leasehold interests 118 94 321 327 Amortization expense related to in place leases and tenant relationships 15,266 12,266 39,483 36,371

Receivables and Other Assets (T

Receivables and Other Assets (Tables)	9 Months Ended
	Sep. 30, 2016
Receivables and Other Assets [Abstract]
Schedule of Receivables and Other Assets	Receivables and other assets consisted of the following as of September 30, 2016 and December 31, 2015 (in thousands): September 30, 2016 December 31, 2015 Tenant receivables, net $ 8,940 $ 5,820 Other receivables, net 11,311 11,882 Deferred financing costs, net 4,529 5,524 Deferred leasing costs, net 19,690 17,923 Straight-line rent receivables, net 72,354 65,543 Prepaid expenses, deposits, equipment and other, net 44,013 34,584 Derivative financial instruments - interest rate swaps — 427 Total $ 160,837 $ 141,703
Summary of Amortization of Deferred Leasing Costs and Deferred Financing Costs	The following is a summary of the amortization of deferred leasing costs and financing costs for the three and nine months ended September 30, 2016 and 2015 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2016 2015 2016 2015 Amortization expense related to deferred leasing costs $ 1,224 $ 1,013 $ 3,368 $ 2,941 Interest expense related to deferred financing costs (1) 331 320 994 985 (1) For the three and nine months ended September 30, 2015, amounts have been adjusted to reflect the retrospective presentation of the early adoption of ASU 2015-03 and 2015-15 as of December 31, 2015.

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2016
Debt Disclosure [Abstract]
Schedule of Debt	Debt consisted of the following as of September 30, 2016 and December 31, 2015 (in thousands): September 30, 2016 December 31, 2015 Unsecured revolving credit facility $ 27,000 $ 218,000 Unsecured term loans 500,000 455,000 Unsecured senior notes 950,000 600,000 Fixed rate mortgages loans 209,797 298,030 Variable rate mortgages loans 39,140 28,988 1,725,937 1,600,018 Deferred financing costs, net (9,853 ) (8,411 ) Discount, net (3,486 ) (911 ) Total $ 1,712,598 $ 1,590,696
Summary of Debt Maturities and Scheduled Principal Debt Repayments	The following table summarizes the debt maturities and scheduled principal repayments of our indebtedness as of September 30, 2016 (in thousands): Year Amount 2016 $ 1,433 2017 87,268 2018 4,333 2019 304,580 2020 76,796 Thereafter 1,251,527 Total $ 1,725,937
Schedule of Amortization of Deferred Financing Costs	As of September 30, 2016 , the future amortization of deferred financing costs is as follows (in thousands): Year Amount 2016 $ 481 2017 1,829 2018 1,757 2019 1,762 2020 1,320 Thereafter 2,704 Total $ 9,853

Derivative Financial Instrume27

Derivative Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instrument Assets and (Liabilities) Held	The following table lists the derivative financial instrument assets and (liabilities) held by us as of September 30, 2016 (in thousands): Notional Amount Index Rate Fair Value Instrument Maturity $ 50,000 LIBOR 1.39 % $ (729 ) Swap 7/17/2019 105,000 LIBOR 1.24 (1,073 ) Swap 7/17/2019 25,480 LIBOR + 1.45% 4.98 (2,224 ) Swap 5/1/2020 6,135 LIBOR + 2.25% 4.04 (243 ) Swap 1/1/2023 4,406 LIBOR + 0.49% 3.52 (597 ) Swap 12/1/2023 The following table lists the derivative financial instrument assets and (liabilities) held by us as of December 31, 2015 (in thousands): Notional Amount Index Rate Fair Value Instrument Maturity $ 100,000 LIBOR 0.86 % $ (142 ) Swap 6/15/2016 50,000 LIBOR 1.39 (71 ) Swap 7/17/2019 105,000 LIBOR 1.24 427 Swap 7/17/2019 26,092 LIBOR + 1.45% 4.98 (2,157 ) Swap 5/1/2020
Gross Fair Value of Derivative Financial Instruments	As of September 30, 2016 and December 31, 2015 , the gross fair value of our derivative financial instruments was as follows (in thousands): Asset Derivatives Liability Derivatives Fair Value Fair Value Derivatives Not Designated as Hedging Instruments: Balance Sheet Location September 30, 2016 December 31, 2015 Balance Sheet Location September 30, 2016 December 31, 2015 Interest rate swaps Receivables and other assets $ — $ 427 Derivative financial instruments $ 4,866 $ 2,370
Schedule of Derivative Liabilities Subject to Master Netting Arrangements	As of September 30, 2016 and December 31, 2015 , we had derivatives subject to enforceable master netting arrangements which allowed for net cash settlement with the respective counterparties (in thousands): September 30, 2016 December 31, 2015 Gross Amounts Amounts Subject to Enforceable Master Netting Arrangements Net Amounts Gross Amounts Amounts Subject to Enforceable Master Netting Arrangements Net Amounts Asset derivatives $ — $ — $ — $ 427 $ (427 ) $ — Liability derivatives 4,866 — 4,866 2,370 (427 ) 1,943
Schedule of Derivative Assets Subject to Master Netting Arrangements	As of September 30, 2016 and December 31, 2015 , we had derivatives subject to enforceable master netting arrangements which allowed for net cash settlement with the respective counterparties (in thousands): September 30, 2016 December 31, 2015 Gross Amounts Amounts Subject to Enforceable Master Netting Arrangements Net Amounts Gross Amounts Amounts Subject to Enforceable Master Netting Arrangements Net Amounts Asset derivatives $ — $ — $ — $ 427 $ (427 ) $ — Liability derivatives 4,866 — 4,866 2,370 (427 ) 1,943

Stockholders' Equity and Part28

Stockholders' Equity and Partners' Capital (Tables)	9 Months Ended
	Sep. 30, 2016
Equity [Abstract]
Schedule of Restricted Common Stock Activity	The following is a summary of our restricted common stock activity during the nine months ended September 30, 2016 and 2015 (in thousands, except weighted average grant date fair value): September 30, 2016 September 30, 2015 Restricted Common Stock Weighted Average Grant Date Fair Value Restricted Common Stock Weighted Average Grant Date Fair Value Beginning balance 487,850 $ 23.13 463,050 $ 20.90 Granted 417,110 29.82 221,076 26.57 Vested (236,749 ) 23.27 (135,213 ) 21.89 Forfeited (24,391 ) 25.93 (21,378 ) 22.70 Ending balance 643,820 $ 27.35 527,535 $ 22.88

Fair Value of Financial Instr29

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2016
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The table below presents our assets and liabilities measured at fair value on a recurring basis as of September 30, 2016 , aggregated by the applicable level in the fair value hierarchy (in thousands): Level 1 Level 2 Level 3 Total Assets: Derivative financial instruments $ — $ — $ — $ — Liabilities: Derivative financial instruments $ — $ 4,866 $ — $ 4,866 The table below presents our assets and liabilities measured at fair value on a recurring basis as of December 31, 2015 , aggregated by the applicable level in the fair value hierarchy (in thousands): Level 1 Level 2 Level 3 Total Assets: Derivative financial instruments $ — $ 427 $ — $ 427 Liabilities: Derivative financial instruments $ — $ 2,370 $ — $ 2,370
Schedule of Fair Value, Assets Measured on Non-Recurring Basis	The table below presents our assets measured at fair value on a non-recurring basis as of December 31, 2015 , aggregated by the applicable level in the fair value hierarchy (in thousands): Level 1 Level 2 Level 3 Total Assets: MOB (1) $ — $ 547 $ — $ 547 (1) During the year ended December 31, 2015, we recognized a $0.9 million impairment charge to the carrying value of an MOB. The estimated fair value as of December 31, 2015 was based upon a pending sales agreement pertaining to this MOB.

Per Share Data of HTA (Tables)

Per Share Data of HTA (Tables)	9 Months Ended
	Sep. 30, 2016
HTA, Inc.
Earnings Per Share
Schedule of Earnings Per Share, Basic and Diluted	The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per share of HTA for the three and nine months ended September 30, 2016 and 2015 (in thousands, except per share data): Three Months Ended September 30, Nine Months Ended September 30, 2016 2015 2016 2015 Numerator: Net income $ 6,639 $ 6,554 $ 30,191 $ 22,984 Net income attributable to noncontrolling interests (212 ) (91 ) (830 ) (425 ) Net income attributable to common stockholders $ 6,427 $ 6,463 $ 29,361 $ 22,559 Denominator: Weighted average shares outstanding - basic 138,807 126,863 134,905 125,750 Dilutive shares 4,331 1,930 3,409 1,930 Weighted average shares outstanding - diluted 143,138 128,793 138,314 127,680 Earnings per common share - basic Net income attributable to common stockholders $ 0.05 $ 0.05 $ 0.22 $ 0.18 Earnings per common share - diluted Net income attributable to common stockholders $ 0.04 $ 0.05 $ 0.21 $ 0.18

Per Unit Data of HTALP (Tables)

Per Unit Data of HTALP (Tables)	9 Months Ended
	Sep. 30, 2016
Healthcare Trust of America Holdings, LP (HTALP)
Earnings Per Share
Schedule of Earnings Per Unit, Basic and Diluted	The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per unit of HTALP for the three and nine months ended September 30, 2016 and 2015 (in thousands, except per unit data): Three Months Ended September 30, Nine Months Ended September 30, 2016 2015 2016 2015 Numerator: Net income $ 6,639 $ 6,554 $ 30,191 $ 22,984 Net income attributable to noncontrolling interests (1 ) (20 ) (28 ) (77 ) Net income attributable to common unitholders $ 6,638 $ 6,534 $ 30,163 $ 22,907 Denominator: Weighted average units outstanding - basic 143,137 128,793 138,314 127,781 Dilutive units — — — — Weighted average units outstanding - diluted 143,137 128,793 138,314 127,781 Earnings per common unit - basic: Net income attributable to common unitholders $ 0.05 $ 0.05 $ 0.22 $ 0.18 Earnings per common unit - diluted: Net income attributable to common unitholders $ 0.05 $ 0.05 $ 0.22 $ 0.18

Supplemental Cash Flow Inform32

Supplemental Cash Flow Information (Tables)	9 Months Ended
	Sep. 30, 2016
Supplemental Cash Flow Elements [Abstract]
Schedule of Supplemental Cash Flow Information	The following is the supplemental cash flow information for the nine months ended September 30, 2016 and 2015 (in thousands): Nine Months Ended September 30, 2016 2015 Supplemental Disclosure of Cash Flow Information: Interest paid $ 39,321 $ 39,570 Income taxes paid 934 790 Supplemental Disclosure of Noncash Investing and Financing Activities: Accrued capital expenditures $ 2,868 $ 1,833 Debt and interest rate swaps assumed in connection with an acquisition 21,156 — Dividend distributions declared, but not paid 43,530 37,712 Issuance of operating partnership units in connection with an acquisition 71,754 — Note receivable included in the consideration of a disposition 3,000 — Redeemable noncontrolling interest assumed in connection with an acquisition 5,449 — Redemption of noncontrolling interests 5,709 —

Organization and Description 33

Organization and Description of Business (Details) ft² in Millions, $ in Billions	9 Months Ended
	Sep. 30, 2016USD ($)ft²marketStates
Organization, Consolidation and Presentation of Financial Statements [Abstract]
General partnership interest (as a percent)	97.00%
Purchased property inception to current date | $	$ 4.2
Gross leasable area of real estate in portfolio (in square feet) | ft²	17.6
Concentration Risk [Line Items]
Percentage of gross leasable area on-campus/aligned	97.00%
Number of states in which the Company operates | States	31
Maximum state gross leasable area (as a percent)	13.00%
Percentage of gross leasable area located in the top 75 Metro statistical areas	92.00%
Minimum
Concentration Risk [Line Items]
Number of markets where the Company is concentrated	20
Maximum
Concentration Risk [Line Items]
Number of markets where the Company is concentrated	25

Summary of Significant Accoun34

Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Building Improvements
Partners' Capital Notes [Abstract]
Depreciation expense	$ 31.1	$ 26.9	$ 86.6	$ 74.9
Healthcare Trust of America Holdings, LP (HTALP)
Partners' Capital Notes [Abstract]
Limited partner's capital, units issued	4,323,095		4,323,095		1,929,942
Limited partner's capital, units outstanding	4,323,095		4,323,095		1,929,942

Investments in Real Estate - Ac

Investments in Real Estate - Acquisitions (Details) - USD ($) $ in Thousands	1 Months Ended	9 Months Ended
	Oct. 26, 2016	Sep. 30, 2016	Sep. 30, 2015
Investments [Abstract]
Closing costs		$ 2,500
Mortgage loans assumed		20,000
Business Acquisition [Line Items]
Land		77,949	$ 13,286
Building and improvements		505,138	229,386
In place leases		50,997	22,414
Below market leases		(12,790)	(8,206)
Above market leases		4,413	1,254
Below market leasehold interests		4,188	2,698
Above market leasehold interests		(50)	(7,725)
Below market debt		360	0
Interest rate swaps		(779)	0
Net assets acquired		629,426	253,107
Other, net		3,540	1,503
Aggregate purchase price		$ 632,966	$ 254,610
Subsequent Event
Business Acquisition [Line Items]
Aggregate purchase price	$ 7,200
Partnership Units
Business Acquisition [Line Items]
Number of operating partnership units issued in acquisition (shares)		2,650,409
Market value of operating partnership units issued in acquisition		$ 71,800

Investments in Real Estate - We

Investments in Real Estate - Weighted Average Lives (Details)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Investments [Abstract]
Acquired intangible assets	9 years 1 month 6 days	26 years 9 months 21 days
Acquired intangible liabilities	8 years 3 months 18 days	52 years 5 months 8 days

Dispositions (Details)

Dispositions (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016USD ($)	Sep. 30, 2015USD ($)	Sep. 30, 2016USD ($)facility	Sep. 30, 2015USD ($)
Disposal Group, Not Discontinued Operation, Disposal Disclosures [Abstract]
Number of senior care facilities disposed (in facilities) | facility			4
Aggregate gross sales price of facilities disposed			$ 26,500
Gain from sale of dispositions of properties	$ 0	$ 152	$ 4,212	$ 152

Intangible Assets and Liabili38

Intangible Assets and Liabilities - Summary of Intangible Assets and Liabilities (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Assets:
Gross	$ 533,535	$ 490,329
Accumulated amortization	(246,868)	(219,334)
Total	$ 286,667	$ 270,995
Weighted Average Remaining Amortization in Years	16 years 1 month 6 days	16 years 7 months 6 days
Liabilities:
Gross	$ 45,757	$ 33,822
Accumulated amortization	(8,829)	(7,211)
Total	$ 36,928	$ 26,611
Weighted Average Remaining Amortization in Years	29 years	38 years
Below market leases
Liabilities:
Gross	$ 34,125	$ 22,240
Weighted Average Remaining Amortization in Years	19 years 1 month 6 days	27 years 2 months 12 days
Above market leasehold interests
Liabilities:
Gross	$ 11,632	$ 11,582
Weighted Average Remaining Amortization in Years	53 years 2 months 12 days	53 years 8 months 12 days
In place leases
Assets:
Gross	$ 291,851	$ 249,824
Weighted Average Remaining Amortization in Years	9 years 10 months 24 days	11 years
Tenant relationships
Assets:
Gross	$ 174,583	$ 180,925
Weighted Average Remaining Amortization in Years	10 years 6 months	10 years 4 months 24 days
Above market leases
Assets:
Gross	$ 28,306	$ 24,974
Weighted Average Remaining Amortization in Years	6 years 4 months 24 days	6 years
Below market leasehold interests
Assets:
Gross	$ 38,795	$ 34,606
Weighted Average Remaining Amortization in Years	60 years 4 months 24 days	63 years

Intangible Assets and Liabili39

Intangible Assets and Liabilities - Summary of Intangible Amortization (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Amortization recorded against rental income related to above or (below) market leases
Schedule of Finite-Lived Intangible Assets and Liabilities [Line Items]
Amortization of intangible assets and liabilities	$ (115)	$ 509	$ 202	$ 1,428
Rental expense related to above or (below) market leasehold interests
Schedule of Finite-Lived Intangible Assets and Liabilities [Line Items]
Amortization of intangible assets and liabilities	118	94	321	327
Amortization expense related to in place leases and tenant relationships
Schedule of Finite-Lived Intangible Assets and Liabilities [Line Items]
Amortization of intangible assets and liabilities	$ 15,266	$ 12,266	$ 39,483	$ 36,371

Receivables and Other Assets -

Receivables and Other Assets - Schedule of Receivables and Other Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Receivables and Other Assets [Abstract]
Tenant receivables, net	$ 8,940	$ 5,820
Other receivables, net	11,311	11,882
Deferred financing costs, net	4,529	5,524
Deferred leasing costs, net	19,690	17,923
Straight-line rent receivables, net	72,354	65,543
Prepaid expenses, deposits, equipment and other, net	44,013	34,584
Derivative financial instruments - interest rate swaps	0	427
Total	$ 160,837	$ 141,703

Receivables and Other Assets 41

Receivables and Other Assets - Amortization (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Receivables and Other Assets [Abstract]
Amortization expense related to deferred leasing costs	$ 1,224	$ 1,013	$ 3,368	$ 2,941
Interest expense related to deferred financing costs	$ 331	$ 320	$ 994	$ 985

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Debt Instrument
Total debt, gross	$ 1,725,937	$ 1,600,018
Deferred financing costs, net	(9,853)	(8,411)
Discount, net	(3,486)	(911)
Total	1,712,598	1,590,696
Unsecured term loans
Debt Instrument
Total debt, gross	500,000	455,000
Unsecured senior notes
Debt Instrument
Total debt, gross	950,000	600,000
Mortgages | Fixed rate mortgages loans
Debt Instrument
Total debt, gross	209,797	298,030
Mortgages | Variable rate mortgages loans
Debt Instrument
Total debt, gross	39,140	28,988
Unsecured revolving credit facility
Debt Instrument
Line of credit facility, amount outstanding	$ 27,000	$ 218,000

Debt - Principal Maturity Sched

Debt - Principal Maturity Schedule (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Debt Disclosure [Abstract]
2,016	$ 1,433
2,017	87,268
2,018	4,333
2,019	304,580
2,020	76,796
Thereafter	1,251,527
Total	$ 1,725,937	$ 1,600,018

Debt - Amortization of Deferred

Debt - Amortization of Deferred Financing Costs (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Debt Disclosure [Abstract]
2,016	$ 481
2,017	1,829
2,018	1,757
2,019	1,762
2,020	1,320
Thereafter	2,704
Total	$ 9,853	$ 8,411

Debt - Textuals (Details)

Debt - Textuals (Details) - USD ($)	Feb. 11, 2015	Sep. 30, 2016	Sep. 26, 2016	Sep. 25, 2016	Jul. 12, 2016	Dec. 31, 2015
Debt Instrument
Outstanding amount		$ 1,725,937,000				$ 1,600,018,000
Unsecured term loans
Debt Instrument
Outstanding amount		$ 500,000,000				455,000,000
Unsecured term loans | $300.0 Million Unsecured Term Loan
Debt Instrument
Basis spread on variable rate (as a percent)		1.15%
Outstanding amount		$ 300,000,000
Unsecured credit agreement, extension option period (in years)		1 year
Weighted average interest rate with interest rate swap impact (as a percent)		1.65%
Unsecured term loans | $200.0 Million Unsecured Term Loan
Debt Instrument
Basis spread on variable rate (as a percent)		1.65%
Debt instrument, face amount		$ 200,000,000	$ 200,000,000	$ 155,000,000
Weighted average interest rate with interest rate swap impact (as a percent)		2.76%
Unsecured senior notes
Debt Instrument
Outstanding amount		$ 950,000,000				$ 600,000,000
Unsecured senior notes | $300.0 Million Unsecured Senior Notes due 2021
Debt Instrument
Debt instrument, face amount		$ 300,000,000
Debt instrument, stated interest rate (as a percent)		3.38%
Debt instrument, percentage of principal amount received (as a percent)		99.21%
Debt instrument, effective interest rate (as a percent)		3.50%
Unsecured senior notes | $300.0 Million Unsecured Senior Notes due 2023
Debt Instrument
Debt instrument, face amount		$ 300,000,000
Debt instrument, stated interest rate (as a percent)		3.70%
Debt instrument, percentage of principal amount received (as a percent)		99.19%
Debt instrument, effective interest rate (as a percent)		3.80%
Unsecured senior notes | $350.0 Million Unsecured Senior Notes due 2026
Debt Instrument
Debt instrument, face amount					$ 350,000,000
Debt instrument, stated interest rate (as a percent)		3.50%
Debt instrument, percentage of principal amount received (as a percent)		99.72%
Debt instrument, effective interest rate (as a percent)		3.53%
Mortgages
Debt Instrument
Weighted average interest rate with interest rate swap impact (as a percent)		5.43%
Weighted average interest rate (as a percent)		5.03%
Minimum | Unsecured term loans | $300.0 Million Unsecured Term Loan
Debt Instrument
Basis spread on variable rate (as a percent)		0.90%
Minimum | Unsecured term loans | $200.0 Million Unsecured Term Loan
Debt Instrument
Basis spread on variable rate (as a percent)		1.50%
Minimum | Mortgages
Debt Instrument
Debt instrument, effective interest rate (as a percent)		1.95%
Maximum | Unsecured term loans | $300.0 Million Unsecured Term Loan
Debt Instrument
Basis spread on variable rate (as a percent)		1.80%
Maximum | Unsecured term loans | $200.0 Million Unsecured Term Loan
Debt Instrument
Basis spread on variable rate (as a percent)		2.45%
Maximum | Mortgages
Debt Instrument
Debt instrument, effective interest rate (as a percent)		6.26%
Unsecured revolving credit facility
Debt Instrument
Line of credit facility, borrowing capacity	$ 850,000,000
Basis spread on variable rate (as a percent)		1.05%
Line of credit facility, commitment fee (as a percent)		0.20%
Unsecured revolving credit facility | Minimum
Debt Instrument
Basis spread on variable rate (as a percent)	0.88%
Line of credit facility, commitment fee (as a percent)	0.13%
Unsecured revolving credit facility | Maximum
Debt Instrument
Basis spread on variable rate (as a percent)	1.55%
Line of credit facility, commitment fee (as a percent)	0.30%

Derivative Financial Instrume46

Derivative Financial Instruments - Table of Derivative Financial Instruments (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Swap at 1.39%
Derivative
Notional Amount	$ 50,000	$ 50,000
Index	LIBOR	LIBOR
Rate (as a percent)	1.39%	1.39%
Derivative liabilities	$ (729)	$ (71)
Swap at 0.86%
Derivative
Notional Amount		$ 100,000
Index		LIBOR
Rate (as a percent)		0.86%
Derivative liabilities		$ (142)
Swap at 1.24%
Derivative
Notional Amount	$ 105,000	$ 105,000
Index	LIBOR	LIBOR
Rate (as a percent)	1.24%	1.24%
Derivative liabilities	$ (1,073)
Derivative assets		$ 427
Swap at 4.98%
Derivative
Notional Amount	$ 25,480	$ 26,092
Index	LIBOR + 1.45%	LIBOR + 1.45%
Rate (as a percent)	4.98%	4.98%
Derivative liabilities	$ (2,224)	$ (2,157)
Swap at 4.98% | LIBOR
Derivative
Basis spread on variable rate (as a percent)	1.45%	1.45%
Swap at 4.04%
Derivative
Notional Amount	$ 6,135
Index	LIBOR + 2.25%
Rate (as a percent)	4.04%
Derivative liabilities	$ (243)
Swap at 4.04% | LIBOR
Derivative
Basis spread on variable rate (as a percent)	2.25%
Swap at 3.52%
Derivative
Notional Amount	$ 4,406
Index	LIBOR + 0.49%
Rate (as a percent)	3.52%
Derivative liabilities	$ (597)
Swap at 3.52% | LIBOR
Derivative
Basis spread on variable rate (as a percent)	0.49%

Derivative Financial Instrume47

Derivative Financial Instruments - Derivative Instruments Fair Value Table (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Derivatives, Fair Value
Asset Derivatives	$ 0	$ 427
Liability Derivatives	4,866	2,370
Not Designated as Hedging Instrument | Interest rate swaps | Receivables and other assets
Derivatives, Fair Value
Asset Derivatives	0	427
Not Designated as Hedging Instrument | Interest rate swaps | Derivative financial instruments
Derivatives, Fair Value
Liability Derivatives	$ 4,866	$ 2,370

Derivative Financial Instrume48

Derivative Financial Instruments - Derivative Offsetting (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Asset derivatives
Asset Derivatives	$ 0	$ 427
Amounts Subject to Enforceable Master Netting Arrangements	0	(427)
Net Amounts	0	0
Liability derivatives
Liability Derivatives	4,866	2,370
Amounts Subject to Enforceable Master Netting Arrangements	0	(427)
Net Amounts	$ 4,866	$ 1,943

Stockholders' Equity and Part49

Stockholders' Equity and Partners' Capital - Textuals (Details)	Oct. 25, 2016$ / shares	Jan. 31, 2016USD ($)	Sep. 30, 2016USD ($)$ / sharesshares	Sep. 30, 2015USD ($)$ / shares	Sep. 30, 2016USD ($)$ / sharesshares	Sep. 30, 2015USD ($)$ / sharesshares	Dec. 31, 2015shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity issued during period					$ 492,500,000
Common Stock Offerings
Issuance of common stock, net					$ 417,163,000	$ 43,649,000
Share price (in usd per share) | $ / shares			$ 29.33		$ 29.33
Common Stock Dividends
Dividends declared (in usd per share) | $ / shares			$ 0.300	$ 0.295	$ 0.890	$ 0.875
LTIP Units
Incentive Plan
Number of forfeited units (in units) | shares							225,000
Restricted Common Stock
Incentive Plan
Number of forfeited units (in units) | shares					24,391	21,378
Nonvested awards, total compensation cost not yet recognized			$ 10,200,000		$ 10,200,000
Period for recognition (in years)					2 years
Restricted Common Stock | General and Administrative Expense
Incentive Plan
Compensation expense			$ 2,100,000	$ 1,400,000	$ 5,100,000	$ 4,500,000
2006 Incentive Plan
Incentive Plan
Number of shares authorized (in shares) | shares			5,000,000		5,000,000
Number of shares available for grant (in shares) | shares			1,921,610		1,921,610
Subsequent Event
Common Stock Dividends
Dividends declared (in usd per share) | $ / shares	$ 0.300
ATM
Common Stock Offerings
Issuance of common stock, net					$ 122,900,000
Share price (in usd per share) | $ / shares			$ 27.82		$ 27.82
Issuance of common stock, net (in shares) | shares					4,418,571
Remaining amount of shares available for issuance			$ 177,100,000		$ 177,100,000
ATM | Maximum
Common Stock Offerings
Maximum amount of common stock authorized		$ 300,000,000
Public Offering
Common Stock Offerings
Issuance of common stock, net					$ 297,800,000
Share price (in usd per share) | $ / shares			$ 30.64		$ 30.64
Issuance of common stock, net (in shares) | shares					9,720,000
Healthcare Trust of America Holdings, LP (HTALP)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend distribution ratio					1
Common Unit Offerings
Issuance of limited partner units in connection with an acquisition (in units) | shares					2,650,409
Issuance of partnership units in connection with an acquisition					$ 71,754,000
Common Stock Dividends
Dividends declared (in usd per share) | $ / shares			$ 0.300	$ 0.295	$ 0.890	$ 0.875

Stockholders' Equity and Part50

Stockholders' Equity and Partners' Capital - Restricted Common Stock Activity (Details) - Restricted Common Stock - $ / shares	9 Months Ended		12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Restricted Common Stock
Balance as of beginning of period (shares)	487,850	463,050	463,050
Granted (shares)	417,110	221,076
Vested (shares)	(236,749)	(135,213)
Forfeited (shares)	(24,391)	(21,378)
Balance as of end of period (shares)	643,820	527,535	487,850
Weighted Average Grant Date Fair Value
Balance as of beginning of period (usd per share)	$ 23.13	$ 20.90	$ 20.90
Granted (usd per share)	29.82	26.57
Vested (usd per share)	23.27	21.89
Forfeited (usd per share)	25.93	22.70
Balance as of end of period (usd per share)	$ 27.35	$ 22.88	$ 23.13

Fair Value of Financial Instr51

Fair Value of Financial Instruments - Assets and Liabilities at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Assets:
Derivative financial instruments, asset	$ 0	$ 427
Liabilities:
Derivative financial instrument, liability	4,866	2,370
Fair Value, Measurements, Recurring
Assets:
Derivative financial instruments, asset	0	427
Liabilities:
Derivative financial instrument, liability	4,866	2,370
Fair Value, Measurements, Recurring | Level 1
Assets:
Derivative financial instruments, asset	0	0
Liabilities:
Derivative financial instrument, liability	0	0
Fair Value, Measurements, Recurring | Level 2
Assets:
Derivative financial instruments, asset	0	427
Liabilities:
Derivative financial instrument, liability	4,866	2,370
Fair Value, Measurements, Recurring | Level 3
Assets:
Derivative financial instruments, asset	0	0
Liabilities:
Derivative financial instrument, liability	$ 0	$ 0

Fair Value of Financial Instr52

Fair Value of Financial Instruments - Assets on Nonrecurring Basis (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Sep. 30, 2016
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Line Items]
Assets: MOB	$ 547,000	$ 0
Impairment on property being marketed for sale	900,000
Level 1
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Line Items]
Assets: MOB	0
Level 2
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Line Items]
Assets: MOB	547,000
Level 3
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Line Items]
Assets: MOB	$ 0

Fair Value of Financial Instr53

Fair Value of Financial Instruments - Textuals (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Fair Value Disclosures [Abstract]
Debt, fair value	$ 1,781,600	$ 1,619,700
Debt, carrying value	$ 1,712,598	$ 1,590,696

Per Share Data of HTA (Details)

Per Share Data of HTA (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Numerator:
Net income		$ 6,639	$ 6,554	$ 30,191	$ 22,984
Net income attributable to noncontrolling interests	[1]	(212)	(91)	(830)	(425)
Net income attributable to common stockholders/unitholders		$ 6,427	$ 6,463	$ 29,361	$ 22,559
Denominator:
Weighted average shares outstanding - basic		138,807	126,863	134,905	125,750
Weighted average number of shares/units outstanding — diluted		143,138	128,793	138,314	127,680
Earnings per common share - basic
Net income attributable to common stockholders (in usd per share)		$ 0.05	$ 0.05	$ 0.22	$ 0.18
Earnings per common share - diluted
Net income attributable to common stockholders (in usd per share)		$ 0.04	$ 0.05	$ 0.21	$ 0.18
HTA, Inc.
Numerator:
Net income		$ 6,639	$ 6,554	$ 30,191	$ 22,984
Net income attributable to noncontrolling interests		(212)	(91)	(830)	(425)
Net income attributable to common stockholders/unitholders		$ 6,427	$ 6,463	$ 29,361	$ 22,559
Denominator:
Weighted average shares outstanding - basic		138,807	126,863	134,905	125,750
Dilutive shares		4,331	1,930	3,409	1,930
Weighted average number of shares/units outstanding — diluted		143,138	128,793	138,314	127,680
Earnings per common share - basic
Net income attributable to common stockholders (in usd per share)		$ 0.05	$ 0.05	$ 0.22	$ 0.18
Earnings per common share - diluted
Net income attributable to common stockholders (in usd per share)		$ 0.04	$ 0.05	$ 0.21	$ 0.18
[1]	Includes amounts attributable to redeemable noncontrolling interests.

Per Unit Data of HTALP (Details

Per Unit Data of HTALP (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Numerator:
Net income		$ 6,639	$ 6,554	$ 30,191	$ 22,984
Net income attributable to noncontrolling interests	[1]	(212)	(91)	(830)	(425)
Net income attributable to common stockholders/unitholders		$ 6,427	$ 6,463	$ 29,361	$ 22,559
Denominator:
Weighted average units outstanding - basic		138,807	126,863	134,905	125,750
Weighted average number of shares/units outstanding — diluted		143,138	128,793	138,314	127,680
Earnings per common unit - basic:
Net income attributable to common unitholders (in usd per share)		$ 0.05	$ 0.05	$ 0.22	$ 0.18
Earnings per common unit - diluted:
Net income attributable to common unitholders (in usd per share)		$ 0.04	$ 0.05	$ 0.21	$ 0.18
Healthcare Trust of America Holdings, LP (HTALP)
Numerator:
Net income		$ 6,639	$ 6,554	$ 30,191	$ 22,984
Net income attributable to noncontrolling interests		(1)	(20)	(28)	(77)
Net income attributable to common stockholders/unitholders		$ 6,638	$ 6,534	$ 30,163	$ 22,907
Denominator:
Weighted average units outstanding - basic		143,137	128,793	138,314	127,781
Dilutive units		0	0	0	0
Weighted average number of shares/units outstanding — diluted		143,137	128,793	138,314	127,781
Earnings per common unit - basic:
Net income attributable to common unitholders (in usd per share)		$ 0.05	$ 0.05	$ 0.22	$ 0.18
Earnings per common unit - diluted:
Net income attributable to common unitholders (in usd per share)		$ 0.05	$ 0.05	$ 0.22	$ 0.18
[1]	Includes amounts attributable to redeemable noncontrolling interests.

Supplemental Cash Flow Inform56

Supplemental Cash Flow Information (Details) - USD ($) shares in Thousands, $ in Thousands	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Supplemental Disclosure of Cash Flow Information:
Interest paid	$ 39,321	$ 39,570
Income taxes paid	934	790
Supplemental Disclosure of Noncash Investing and Financing Activities:
Accrued capital expenditures	2,868	1,833
Debt and interest rate swaps assumed in connection with an acquisition	21,156	0
Dividend distributions declared, but not paid	$ 43,530	$ 37,712
Issuance of operating partnership units in connection with an acquisition	71,754	0
Note receivable included in the consideration of a disposition	$ 3,000	$ 0
Redeemable noncontrolling interest assumed in connection with an acquisition	5,449	0
Redemption of noncontrolling interests	$ 5,709	$ 0